The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

Merck KGaA, Darmstadt, Germany has closed the acquisition of SpringWorks Therapeutics Inc. for an enterprise value of $3.4 billion.

ProFound Therapeutics, a company pioneering the expanded human proteome to develop medicines, has announced a four-year ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, with a simultaneous closing to ...

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

AAPS has announced the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San ...

© Vetter Pharma International GmbH: Vetter marks the start of new clinical site construction with groundbreaking ceremony.